# Alessa Brasil Tecnologia Ltda.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alessa-brasil-tecnologia-ltda

- Industry: Internet
- Headquarters: Sao Paulo, Brazil
- Website: www.theia.com.br
- Total disclosed funding: $6.4M
- Latest round: Seed (Apr 13, 2022)
- Investors on record: 3

## About

Alessa Brasil Tecnologia Ltda. is a healthcare technology company specializing in innovative solutions that enhance patient care through advanced medical technologies, personalized treatment plans, and comprehensive healthcare services.Founded in 2019 in Sao Paulo, Brazil, Alessa Brasil Tecnologia Ltda. focuses on delivering healthcare solutions tailored to patient needs. The company has successfully completed 2 deals to date, with its most recent funding round occurring on April 13, 2022, where it raised BRL 30 million in Seed funding led by 8VC and supported by Canaan Partners and Kaszek Ventures. The founders, Amanda Krepp, Flavia Deutsch, and Paula Crespi, have a background in healthcare innovation, with Flavia Deutsch currently serving as CEO.Alessa specializes in providing comprehensive healthcare solutions tailored to meet the unique needs of its patients. Its core offerings include a variety of services and products aimed at improving patient care through the integration of advanced medical technologies and personalized treatment plans. The company addresses various healthcare challenges, particularly in diagnostics and therapeutic interventions, serving patients seeking specialized medical attention, healthcare professionals, and partners across North America and Europe. Alessa's services are designed to enhance patient engagement and promote better health outcomes through customized medical solutions.Alessa's revenue model combines direct-to-consumer services with partnerships with healthcare providers. Transactions occur through individualized service plans that cater to specific patient medical needs, supported by structured agreements for ongoing care. Pricing strategies accommodate varying financial capabilities, focusing on delivering value through flagship offerings. Revenue is primarily generated from service fees collected directly from patients and collaborative contracts with healthcare institutions, ensuring a steady income flow based on the quality and effectiveness of its services.Following the Seed funding round completed on April 13, 2022, where Alessa raised BRL 30 million, the company intends to invest this capital in enhancing its technology and operations. Alessa plans to strengthen its partnerships with health plans and is exploring the launch of new products designed to meet emerging healthcare demands. The company is also looking to expand its market presence beyond Brazil into additional regions, focusing on North America and Europe, with specific strategies to be developed in the coming years.

## Funding rounds

- Seed, Apr 13, 2022, $6.4M — Canaan Partners, Kaszek Ventures, 8VC

## Investors

- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Seed
- Kaszek Ventures (https://capitalatlas.ai/funds/kaszek-ventures) — Seed
- 8VC (https://capitalatlas.ai/funds/8vc) — Seed